🇺🇸 Hepa-B in United States

10 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 10

Most-reported reactions

1. Abscess — 1 report (10%)
2. Anaemia — 1 report (10%)
3. Anal Atresia — 1 report (10%)
4. Anal Fissure — 1 report (10%)
5. Aphthous Ulcer — 1 report (10%)
6. Apnoea — 1 report (10%)
7. Arthralgia — 1 report (10%)
8. Atrial Septal Defect — 1 report (10%)
9. Brain Injury — 1 report (10%)
10. Brain Malformation — 1 report (10%)

Source database →

Frequently asked questions

Is Hepa-B approved in United States?

Hepa-B does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Hepa-B in United States?

International Centre for Diarrhoeal Disease Research, Bangladesh is the originator. The local marketing authorisation holder may differ — check the official source linked above.